Marrow Access Technologies
PrivateLast Round
Seed Round
Apr 9, 2026
Total Funding Raised
$3.34M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Marrow Access Technologies is a medical device company that develops and commercializes orthopedic surgical solutions, including the SmartShot device, for marrow stimulation to repair and regenerate cartilage and other soft tissue.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Marrow Access Technologies Comparables
Compare Marrow Access Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Askel Healthcare | 74% | |
| Arthrex | 72% | |
| Stryker Corporation | 72% |
Marrow Access Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 9, 2026 | ||||
| Debt | Mar 4, 2026 | ||||
| Seed | Mar 4, 2024 | ||||
| Early Funding | Nov 13, 2018 |
Marrow Access Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Tech Center | Seed Round |
| KOFA Healthcare | Seed Round |
| Minnesota Department of Employment and Economic Development | Seed Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 37% MoM.
- May 17, 2026
Monthly visitors increased 46% MoM, from 808 to 1.2K.
Marrow Access Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Marrow Access Technologies's valuation, stock price, and market status.
Is Marrow Access Technologies a public or private company?
Marrow Access Technologies is a private company.
What is the current stock price of Marrow Access Technologies?
Marrow Access Technologies is a private company with no public stock price. No recent secondary market data is available.
How much is Marrow Access Technologies worth (valuation)?
Valuation information for Marrow Access Technologies is not publicly available.
Can I buy Marrow Access Technologies stock?
Marrow Access Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Marrow Access Technologies's last funding round?
Marrow Access Technologies's most recent funding round was Seed Round on April 9, 2026.
Who are the main investors in Marrow Access Technologies?
Key investors in Marrow Access Technologies include Plug and Play Tech Center, KOFA Healthcare, Minnesota Department of Employment and Economic Development.
Will Marrow Access Technologies IPO soon?
No public IPO plans have been announced for Marrow Access Technologies.
How can I track Marrow Access Technologies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Marrow Access Technologies's secondary market activity and sign up for updates.